SCHEMBL29619004

SCHEMBL29619004

Cc1noc(C)c1-c1cc(N)ccc1OCCN1CCOCC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.49
BRD2 P25440 2/20 0.49
BRD3 Q15059 2/20 0.49
CYP1A2 P05177 4/20 0.48
CYP3A4 P08684 4/20 0.48
ALOX15 P16050 2/20 0.48
CYP2C19 P33261 1/20 0.48
CREBBP Q92793 4/20 0.47
CLK4 Q9HAZ1 3/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.45
CYP2D6 P10635 2/20 0.45
POLB P06746 1/20 0.45
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PTPN1 P18031 1/20 0.43
NPC1 O15118 1/20 0.43
CYP2C9 P11712 1/20 0.43
AXL P30530 1/20 0.42
SYK P43405 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24398370 0.91 BRD4 (0.47) BRD4BRD2BRD3PTPN1
SCHEMBL29619013 0.83 BRD4 (0.48) BRD4BRD2BRD3CYP1A2CYP3A4
SCHEMBL29619075 0.79 BRD4 (0.45) BRD4BRD2BRD3CREBBP
SCHEMBL29619153 0.79 HTR2A (0.51) BRD4BRD2BRD3
SCHEMBL30962888 0.78 POLB (0.59) ALDH1A1POLBNPC1SYK
SCHEMBL1166030 0.77 HTR2A (0.61)
SCHEMBL29619005 0.75 ESR1 (0.35) BRD4BRD2BRD3
SCHEMBL29619001 0.75 ESR1 (0.35) BRD4BRD2BRD3
SCHEMBL3213395 0.75 POLB (0.59) ALDH1A1POLBNPC1SYK
SCHEMBL31677655 0.75 SMN1; SMN2 (0.46) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4236942-A1 ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2023-09-06 EP disclosed
WO-2022093850-A1 ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2022-05-05 WO disclosed